These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 363629

  • 21. [Results in the treatment of obesity by Mazindol (AN 448 Sandoz) in hospitalized subjects using the method of double-blind trial (author's transl)].
    Kreze A, Velemínsky J, Toman A.
    Bratisl Lek Listy; 1976 May; 65(5):537-43. PubMed ID: 788862
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Maziniol in the treatment of obesity.
    Sedgwick JP.
    Practitioner; 1975 Mar; 214(1281):418-20. PubMed ID: 1096123
    [No Abstract] [Full Text] [Related]

  • 28. [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
    Delitala G, Alagna S, Masala A.
    Clin Ter; 1977 Jun 30; 81(6):547-54. PubMed ID: 884939
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of obesity: cost-benefit assessment of behavioral therapy, placebo, and two anorectic drugs.
    Dahms WT, Molitch ME, Bray GA, Greenway FL, Atkinson RL, Hamilton K.
    Am J Clin Nutr; 1978 May 30; 31(5):774-8. PubMed ID: 417615
    [Abstract] [Full Text] [Related]

  • 32. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
    Gołebiowska M, Chlebna-Sokoł D, Mastalska A, Zwaigzne-Raczyńska J.
    Przegl Lek; 1981 May 30; 38(2):311-4. PubMed ID: 7017826
    [No Abstract] [Full Text] [Related]

  • 33. Double blind evaluation of long acting diethylpropion hydrochloride in obese patients from a general practice.
    Carney DE, Tweddell ED.
    Med J Aust; 1975 Jan 04; 1(1):13-5. PubMed ID: 1092973
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R, Piazzini M, Conti C, Papi L, Strazzulla G, Matassi L.
    Clin Ter; 1987 Mar 15; 120(5):385-91. PubMed ID: 2953538
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An overview of the efficacy and safety of fenfluramine and mazindol in the treatment of obesity.
    Stahl KA, Imperiale TF.
    Arch Fam Med; 1993 Oct 15; 2(10):1033-8. PubMed ID: 8111484
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.